President Donald J. Trump signed a new memorandum that aims to crack down on “misleading” direct-to-consumer pharmaceutical advertisements.

Subscribe Login Register Log out My Profile Subscriber Services Search EBLADE ENTER-TO-WIN BLADE REWARDS BLADE VAULT / REPRINTS OBITUARIES JOBS CLASSIFIEDS BLADE HOMES HOMES WEEKLY ADS EVENTS CONTACT ...